Addex Therapeutics Ltd (FRA:APE)
Germany flag Germany · Delayed Price · Currency is EUR
0.0420
-0.0010 (-2.33%)
At close: Sep 22, 2025

Addex Therapeutics Statistics

Total Valuation

FRA:APE has a market cap or net worth of EUR 6.83 million. The enterprise value is 4.41 million.

Market Cap6.83M
Enterprise Value 4.41M

Important Dates

The last earnings date was Monday, September 1, 2025.

Earnings Date Sep 1, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 98.35M
Shares Outstanding n/a
Shares Change (YoY) +17.91%
Shares Change (QoQ) +0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 26.11M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 38.15
PB Ratio 0.88
P/TBV Ratio 0.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.68
EV / Sales 24.69
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -2.86

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.

Current Ratio 2.31
Quick Ratio 2.03
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.03
Interest Coverage -1,161.92

Financial Efficiency

Return on equity (ROE) is -61.91% and return on invested capital (ROIC) is -15.09%.

Return on Equity (ROE) -61.91%
Return on Assets (ROA) -13.55%
Return on Invested Capital (ROIC) -15.09%
Return on Capital Employed (ROCE) -32.72%
Revenue Per Employee 89,556
Profits Per Employee -3.24M
Employee Count2
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 0.05
200-Day Moving Average n/a
Relative Strength Index (RSI) 49.29
Average Volume (20 Days) n/a

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:APE had revenue of EUR 179,111 and -6.48 million in losses. Loss per share was -0.06.

Revenue179,111
Gross Profit -110,900
Operating Income -2.58M
Pretax Income -6.58M
Net Income -6.48M
EBITDA -2.49M
EBIT -2.58M
Loss Per Share -0.06
Full Income Statement

Balance Sheet

The company has 2.46 million in cash and 41,101 in debt, giving a net cash position of 2.42 million.

Cash & Cash Equivalents 2.46M
Total Debt 41,101
Net Cash 2.42M
Net Cash Per Share n/a
Equity (Book Value) 7.72M
Book Value Per Share 0.08
Working Capital 1.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.54 million and capital expenditures -1,363, giving a free cash flow of -1.54 million.

Operating Cash Flow -1.54M
Capital Expenditures -1,363
Free Cash Flow -1.54M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin -61.92%
Operating Margin -1,438.85%
Pretax Margin -3,675.86%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

FRA:APE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.91%
Shareholder Yield n/a
Earnings Yield -94.80%
FCF Yield -22.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2